Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Ophthotech Corp. (OPHT)
Ophthotech Corp. (OPHT) Actualités

OPHT

OPHTHOTECH CORP. (OPHT)

Ophthotech Corp.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OPHT

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
18/04/2019	12h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OPHT	Ophthotech Corp.
16/04/2019	22h28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPHT	Ophthotech Corp.
16/04/2019	13h30	Business Wire	Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases & Change...	NASDAQ:OPHT	Ophthotech Corp.
11/04/2019	22h05	Business Wire	Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases	NASDAQ:OPHT	Ophthotech Corp.
04/04/2019	00h13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPHT	Ophthotech Corp.
14/03/2019	13h00	Business Wire	Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day	NASDAQ:OPHT	Ophthotech Corp.
06/03/2019	14h00	Business Wire	Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference	NASDAQ:OPHT	Ophthotech Corp.
01/03/2019	12h30	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:OPHT	Ophthotech Corp.
28/02/2019	23h38	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OPHT	Ophthotech Corp.
28/02/2019	23h37	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:OPHT	Ophthotech Corp.
26/02/2019	13h15	Business Wire	Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results	NASDAQ:OPHT	Ophthotech Corp.
19/02/2019	14h00	Business Wire	Ophthotech Corp. to Report Fourth Quarter & Full Year 2018 Financial Results & Host Conference Call on Tuesday, February 26, ...	NASDAQ:OPHT	Ophthotech Corp.
14/02/2019	22h26	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPHT	Ophthotech Corp.
03/01/2019	23h37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OPHT	Ophthotech Corp.
03/01/2019	14h00	Business Wire	Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference	NASDAQ:OPHT	Ophthotech Corp.
02/01/2019	14h00	Business Wire	Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors	NASDAQ:OPHT	Ophthotech Corp.
12/12/2018	22h05	Business Wire	Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of...	NASDAQ:OPHT	Ophthotech Corp.
12/11/2018	13h30	Business Wire	Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular...	NASDAQ:OPHT	Ophthotech Corp.
09/11/2018	21h27	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OPHT	Ophthotech Corp.
02/11/2018	22h39	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:OPHT	Ophthotech Corp.
02/11/2018	21h13	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:OPHT	Ophthotech Corp.
02/11/2018	14h11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OPHT	Ophthotech Corp.
31/10/2018	11h35	Business Wire	Ophthotech Reports Third Quarter 2018 Financial and Operating Results	NASDAQ:OPHT	Ophthotech Corp.
31/10/2018	11h32	Business Wire	Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Tre...	NASDAQ:OPHT	Ophthotech Corp.
31/10/2018	11h30	Business Wire	Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4	NASDAQ:OPHT	Ophthotech Corp.
23/10/2018	13h30	Business Wire	Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018	NASDAQ:OPHT	Ophthotech Corp.
04/10/2018	13h30	Business Wire	Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic At...	NASDAQ:OPHT	Ophthotech Corp.
03/10/2018	13h30	Business Wire	Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference	NASDAQ:OPHT	Ophthotech Corp.
22/08/2018	13h30	Business Wire	Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa P...	NASDAQ:OPHT	Ophthotech Corp.
16/08/2018	12h07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OPHT	Ophthotech Corp.